In the last years, several studies also investigated the impact of germline monoallelic MUTYH pathogenic variants in genetic susceptibility to the development of BC, OC, or prostate cancer, showing increased risk rates associated with heterozygosity [79]. The gene discussed is MUTYH; the disease is prostate carcinoma.